GGrantIndex
Sort

25,944 grants matching neurodegeneration

MOTOR NEURON DISEASE--A PROGRAM PROJECT

$975,773
University Of Chicago · P01 · FY2002 · NS

An automated device for quantifying DNA damage

$975,449
Christopher Ross · Engineering Resources Group, Inc. · R44 · FY2025 · ES

Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs

$975,429
Maria Maccecchini · Annovis Bio, Inc. · U01 · FY2020 · AG

MOTOR NEURON DISEASE--A PROGRAM PROJECT

$975,174
University Of Chicago · P01 · FY2001 · NS

"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"

$974,957
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG

"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"

$974,758
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG

Clinical Investigations of Inborn Errors of Metabolism

$974,404
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD

"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"

$973,393
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG

Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses

$972,873
Fang Yu · Arizona State University-Tempe Campus · R01 · FY2023 · AG

Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related Dementias

$972,457
Michael Alosco · Boston University Medical Campus · R01 · FY2025 · NS

Exosome based therapeutics in Huntington's disease

$972,449
Neil Aronin · Univ Of Massachusetts Med Sch Worcester · UH3 · FY2017 · TR

Longitudinal imaging of microglial activation in different clinical variants of Alzheimer's disease

$972,355
William Charles Kreisl · Columbia University Health Sciences · R01 · FY2020 · AG

Neuroprotective role of GLP-1 receptor agonists

$971,839
Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG

Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia

$971,228
Ariel Gerard Gildengers · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG

"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"

$971,032
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG

The role of DNA damage in human disease: Neurodegeneration and Cancer

$970,238
Philip J Brooks · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA

DNA repair dysfunction in neurodegeneration

$969,456
Vilhelm A Bohr · National Institute On Aging · ZIA · FY2017 · AG

Stress Granules and the Biology of TDP-43

$969,140
Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2015 · ES

Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)

$968,867
Robert Lee Newton · Lsu Pennington Biomedical Research Ctr · R01 · FY2020 · AG

Core E: Biosample Core

$968,277
Ho Wh Yu · University Of Pennsylvania · U19 · FY2024 · AG

CIRCULATING CNS CELL-DERIVED EXTRACELLULAR VESICLE BASED BIOMARKERS TO IDENTIFY NEURODEGENERATION AND GLIAL ACTIVATION IN MULTIPLE SCLEROSIS

$966,758
The Johns Hopkins University · · FY2022 · Defense Health Agency

Single Cell Characterization of FTLD-GRN

$965,344
Eric J Huang · University Of California, San Francisco · R01 · FY2025 · NS

Reimagining Precision Medicine Approaches to AD Diagnosis

$964,640
Gil Dan Rabinovici · University Of California, San Francisco · R35 · FY2024 · AG

The structural and functional connectome across Alzheimer's disease subtypes

$964,413
John M Ringman · University Of Southern California · U01 · FY2018 · AG

Reimagining Precision Medicine Approaches to AD Diagnosis

$964,092
Gil Dan Rabinovici · University Of California, San Francisco · R35 · FY2023 · AG